Delivery Order SPE2DB22D9367-SPE2DB24FSY54
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,542.80 contract is for the delivery of 4,565,862,751 units of the prescription medication ondansetron ODT 8 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,045.09 contract is for the delivery of 4,566,450,193 units of Ondansetron HCL 4 mg tablets by November 18, 2024. The award is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.65 order is for 500 units of the prescription medication Ondansetron HCL 4 mg tablet. The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 held by DMS Pharmaceutical Group with DLA, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $1,104.48, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including both common and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,010.95 firm fixed-price contract is for the supply of 4,566,851,320 tablets of the prescription drug Ondansetron Hydrochloride 4 mg. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,587.62 contract is for the delivery of Ondansetron ODT 8 mg tablets. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,083.86 firm fixed-price contract is for the delivery of 4565006417 Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of June 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the issuance of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,835.84 firm fixed-price delivery order is for the supply of 4,565,044,224 units of the drug ondansetron hydrochloride. The delivery order is being fulfilled under a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,908.40, is for the delivery of Ondansetron 8mg tablets in 30-count packages. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...